The Company will update its shareholders on its definitive share exchange agreement with Core Optics and how it will strengthen Coretec’s structure and operations, and spur revenue and the commercialization of Endurion ANN ARBOR, Mich., March 11, 2024 (GLOBE NEWSWIRE) — The Coretec Group (OTCQB: CRTG), developers of silicon anode active materials for lithium-ion batteries, and cyclohexasilane […]

Read More

Proposed divestiture of Endpoint Clinical and Fortrea Patient Access businesses further streamlines Fortrea’s strategic focus as a pure-play contract research organization Creates standalone best-in-class Randomization and Trial Supply Management and Patient Access solutions positioned for differentiation and growth DURHAM, N.C., March 11, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract […]

Read More